November 26th – Comprehensive report: The number of single-day coronavirus death in the United States reached 2,157 on November 24, the first time since May that the number of coronavirus death exceeded 2,000.
On the 25th, the U.S. Food and Drug Administration approved the first “new generation” test method, which can measure the number of neutralizing antibodies produced by the human immune system after exposure to the virus, aiming to judge a person’s resistance to infection.
According to Reuters, the number of single-day death in the United States reached 2,157 on November 24, and another 170,000 people were infected. However, the day with the highest number of death in the United States is still April 14, when 2,806 deaths were recorded. However, it is reported that this one-day figure is sometimes higher than the actual number, because of the lag in statistics, resulting in a large number of registrations on a certain day.
On the 24th local time, the number of hospitalizations for the coronavirus in the United States also reached a record 87,000, and major infectious disease officials in the United States urged people to hold as few Thanksgiving parties as possible.
Fauci issued a final appeal before Thanksgiving on the 25th, urging people to “sacrifice” the Thanksgiving plan to help stop the spread of the novel coronavirus. He pointed out: “Indoor gatherings should be kept as small as possible. We all know how difficult it is…but by making such sacrifices, you will prevent people from getting infected.”
Fauci is reportedly optimistic about the fight against the pandemic.” The vaccine is right around the corner,” he said. “If we can stay a little longer, continue to do the simple precautions we’ve been talking about — masks, social distancing, avoiding crowds, especially indoors. If we do these things, we will get through this. So this is my last request before the holiday season.” He said that if people do not follow his advice, the United States may see “another surge in infections” in three weeks.
On the same day, the U.S. Food and Drug Administration approved the first antibody test that can measure the number of neutralizing antibodies produced by the human immune system after exposure to the virus, which is a “new generation” of COVID-19 testing methods aimed at judging a person’s resistance to infection.
According to the report, the human immune system will produce antibodies to fight against viruses and other foreign pathogens that invade the human body. It is not clear how much protection antibodies can provide and how long that protection will last in the case of COVID-19, but the test can help researchers better understand the role of COVID-19 antibodies in immune protection.
The test differs from many previously authorized COVID-19 antibody tests because it measures specific levels of COVID-19 neutralizing antibodies in the body. The U.S. Food and Drug Administration has previously approved some tests to assess antibody levels, but they are not specifically used to neutralize antibodies.